PATENT CLAIM ANALYSIS

Application Number: 15913750
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "081000"]

Abstract:
A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host. A process for controlling retrovirus transmission within a population includes the administration to a subpopulation at high risk for contracting an immunodeficiency retroviral infection the detailed combination prior to sexual exposure to a source of immunodeficiency retrovirus so as to preclude the immunodeficiency retrovirus from becoming self-replicating in a member of the subpopulation.

Claim (Index 1):
A process of protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus comprising:\n (a) selecting a primate host not infected with the immunodeficiency retrovirus, and (b) administering directly to the primate host a combination comprising:\n i. a pharmaceutically effective amount of emtricitabine; and \n ii. a pharmaceutically effective amount of tenofovir or a tenofovir prodrug, \n wherein the combination is administered orally prior to the exposure of the primate host to the immunodeficiency retrovirus, thereby protecting the primate host from infection with the immunodeficiency retrovirus.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 2.13889
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14679887', '15406344', '11669547', '12574881', '12864431']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737723773378951
- 35 USC 102 Novelty (BERT): 0.6462934687291721
- Combined Prediction Score: 0.7610244864770228
- Mean Citation Score: 470.371306
- Max Citation Score: 603.2725
- Similarity Product: 586.4900397375225

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test